Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanyan Ni

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Neuroscience|April 25, 2022
Cellular Reprogramming and Its Potential Application in Alzheimer's DiseaseChao Zhou, Wanyan Ni, Taiyang Zhu, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2024
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer's DiseaseMengxin Zhu, Yang Liu, Chen Chen, et al.
CNS Neuroscience & Therapeutics|February 16, 2023
Gain-of-function of progesterone receptor membrane component 2 ameliorates ischemic brain injuryChao Zhou, Taiyang Zhu, Wanyan Ni, et al.
Scientific Reports|May 11, 2025
A transcriptomic and proteomic analysis and comparison of human brain tissue from patients with and without epilepsyTaiyang Zhu, Yan Zhou, Lei Zhang, et al.
Alzheimer'S Research & Therapy|February 16, 2023
Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer's disease in APP/PS1 mouseShang Wang, Taiyang Zhu, Wanyan Ni, et al.
Molecular Neurobiology|May 28, 2025
Late-Stage Activation of Toll-like receptor 3 Alleviates Cognitive Impairment and Neuropathology in an Alzheimer's Disease Mouse ModelTaiyang Zhu, Fanyu Shen, Xiao Jia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Neuroscience|April 25, 2022
Cellular Reprogramming and Its Potential Application in Alzheimer's DiseaseChao Zhou, Wanyan Ni, Taiyang Zhu, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2024
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer's DiseaseMengxin Zhu, Yang Liu, Chen Chen, et al.
CNS Neuroscience & Therapeutics|February 16, 2023
Gain-of-function of progesterone receptor membrane component 2 ameliorates ischemic brain injuryChao Zhou, Taiyang Zhu, Wanyan Ni, et al.
Scientific Reports|May 11, 2025
A transcriptomic and proteomic analysis and comparison of human brain tissue from patients with and without epilepsyTaiyang Zhu, Yan Zhou, Lei Zhang, et al.
Alzheimer'S Research & Therapy|February 16, 2023
Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer's disease in APP/PS1 mouseShang Wang, Taiyang Zhu, Wanyan Ni, et al.
Molecular Neurobiology|May 28, 2025
Late-Stage Activation of Toll-like receptor 3 Alleviates Cognitive Impairment and Neuropathology in an Alzheimer's Disease Mouse ModelTaiyang Zhu, Fanyu Shen, Xiao Jia, et al.
Pageof 1